From the 1Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL; 2Departments of Psychobiology and Gynecology, Universidade Federal de São Paulo, São Paulo, Brazil; 3Department of Neurology, University at Buffalo School of Medicine, State University of New York, Buffalo, NY; and 4Department of Medicine, University of Kentucky College of Medicine, Lexington, KY.
Received July 4, 2014; revised and accepted August 25, 2014.
Funding/support: None.
Financial disclosure/conflicts of interest: H.A., H.H., and B.P. have no conflicts of interest to disclose. T.G. is the inventor of US Patent 6,310,098 (owned by the University of Rochester) covering the use of gabapentin for treating hot flashes. T.G. does not receive royalties on the sales of generic gabapentin or of brand name Neurontin for any use. T.G. may receive royalties on the sales of a gabapentin-related drug only if such drug receives regulatory approval for treating hot flashes, which has not occurred to date. T.G. has received financial support for research and honoraria for speaking engagements from Teva Pharmaceuticals.
Address correspondence to: Hrayr Attarian, MD, Department of Neurology, Northwestern University Feinberg School of Medicine, Suite 524, 710 N Lake Shore Drive, Chicago, IL 60611. E-mail: [email protected]
